Last 12 months
Inside the activity.
0 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 7 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2023 Filed Jun 1, 2023 01:29 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 1 | $198.66 | $198.66 |
DisclosureSEC source: 0001478242-23-000077 · wk-form4_1685582982.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: No plan indicated Ownership: Indirect · By GRAT Disclosed balance after: 0 F1 · ownership.nature: Held by the Knightly March 2022 Grantor Retained Annuity Trust, dated March 30, 2022 ("GRAT") Read SEC document |
| May 10, 2023 Filed May 12, 2023 21:19 UTC |
DANHAKL JOHN GDirector
|
GrantCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000073 · wf-form4_168392633750277.xml · nonDerivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 26,402 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in the Danhakl Revocable Family Trust. Read SEC document |
| May 10, 2023 Filed May 12, 2023 21:16 UTC |
Burt CarolDirector
|
GrantCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000070 · wf-form4_168392615605802.xml · nonDerivative · entry 1 Burt Carol · CIK 0001493926 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Trust Disclosed balance after: 5,962 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. F2 · ownership.nature: Shares held in Carol Burt Hilliard Revocable Trust. Read SEC document |
| May 10, 2023 Filed May 12, 2023 21:20 UTC |
LEONARD JOHN MDirector
|
GrantCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000075 · wf-form4_168392643994809.xml · nonDerivative · entry 1 LEONARD JOHN M · CIK 0001563584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,736 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 10, 2023 Filed May 12, 2023 21:20 UTC |
Fasano JimDirector
|
GrantCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000074 · wf-form4_168392639622721.xml · nonDerivative · entry 1 Fasano Jim · CIK 0001633043 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,063 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 10, 2023 Filed May 12, 2023 21:18 UTC |
Stamps Sheila ADirector
|
GrantCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000072 · wf-form4_168392628047706.xml · nonDerivative · entry 1 Stamps Sheila A · CIK 0001600782 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,058 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 10, 2023 Filed May 12, 2023 21:17 UTC |
Wims Morris LeslieDirector
|
GrantCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000071 · wf-form4_168392621113058.xml · nonDerivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,058 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 10, 2023 Filed May 12, 2023 21:15 UTC |
GOGGINS COLLEEN ADirector
|
GrantCommon Stock | 1,063 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000069 · wf-form4_168392610113158.xml · nonDerivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,243 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document |
| May 10, 2023 Filed Feb 8, 2024 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 159 | $188.08 | $29,904.72 |
DisclosureSEC source: 0001478242-24-000011 · wk-form5_1707430480.xml · derivative · entry 2 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,294 Underlying: Common Stock · 159 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 10, 2023 Filed Feb 8, 2024 22:15 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 147 | $188.08 | $27,647.76 |
DisclosureSEC source: 0001478242-24-000012 · wk-form5_1707430544.xml · derivative · entry 2 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 740 Underlying: Common Stock · 147 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| May 10, 2023 Filed Feb 8, 2024 22:13 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 187 | $188.08 | $35,170.96 |
DisclosureSEC source: 0001478242-24-000010 · wk-form5_1707430384.xml · derivative · entry 2 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,981 Underlying: Common Stock · 187 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:13 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 2,772 | $225.57 | $625,280.04 |
DisclosureSEC source: 0001478242-23-000052 · wf-form4_167667198104509.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,973 Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 22:13 UTC |
Knightly Kevin CSee Remarks
|
SaleCommon Stock | 1,674 | $225.68 | $377,788.32 |
DisclosureSEC source: 0001478242-23-000052 · wf-form4_167667198104509.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,745 Read SEC document |
| February 14, 2023 Filed Feb 15, 2023 22:58 UTC |
Sherbet EricSee Remarks
|
SaleCommon Stock | 1,000 | $230.00 | $230,000.00 |
DisclosureSEC source: 0001478242-23-000045 · wf-form4_167650191070248.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,053 Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 23:00 UTC |
Cherofsky KeriannSee Remarks
|
GrantStock Appreciation Right · Derivative | 1,373 | $0.00 Strike: $232.11 | $0.00 |
DisclosureSEC source: 0001478242-23-000047 · wf-form4_167650202678242.xml · derivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,373 Underlying: Common Stock · 1,373 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 13, 2024. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 18:02 UTC |
Panagos ConstantinosSee Remarks
|
GrantStock Appreciation Right · Derivative | 10,300 | $0.00 Strike: $232.11 | $0.00 |
DisclosureSEC source: 0001478242-23-000050 · wf-form4_167650215801104.xml · derivative · entry 1 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,300 Underlying: Common Stock · 10,300 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 13, 2024. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 23:02 UTC |
Knightly Kevin CSee Remarks
|
GrantStock Appreciation Right · Derivative | 6,866 | $0.00 Strike: $232.11 | $0.00 |
DisclosureSEC source: 0001478242-23-000049 · wf-form4_167650211382790.xml · derivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,866 Underlying: Common Stock · 6,866 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 13, 2024. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 23:01 UTC |
Bruehlman Ronald ESee Remarks
|
GrantStock Appreciation Right · Derivative | 20,600 | $0.00 Strike: $232.11 | $0.00 |
DisclosureSEC source: 0001478242-23-000048 · wf-form4_167650206856410.xml · derivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,600 Underlying: Common Stock · 20,600 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 13, 2024. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:59 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantStock Appreciation Right · Derivative | 72,102 | $0.00 Strike: $232.11 | $0.00 |
DisclosureSEC source: 0001478242-23-000046 · wf-form4_167650196901957.xml · derivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,102 Underlying: Common Stock · 72,102 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 13, 2024. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 22:58 UTC |
Sherbet EricSee Remarks
|
GrantStock Appreciation Right · Derivative | 8,583 | $0.00 Strike: $232.11 | $0.00 |
DisclosureSEC source: 0001478242-23-000045 · wf-form4_167650191070248.xml · derivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,583 Underlying: Common Stock · 8,583 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock appreciation right vests in three annual installments beginning on February 13, 2024. Read SEC document |
| February 13, 2023 Filed Feb 8, 2024 22:14 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 130 | $232.11 | $30,174.30 |
DisclosureSEC source: 0001478242-24-000011 · wk-form5_1707430480.xml · derivative · entry 1 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,135 Underlying: Common Stock · 130 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 13, 2023 Filed Feb 8, 2024 22:15 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 118 | $232.11 | $27,388.98 |
DisclosureSEC source: 0001478242-24-000012 · wk-form5_1707430544.xml · derivative · entry 1 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 593 Underlying: Common Stock · 118 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 13, 2023 Filed Feb 8, 2024 22:13 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 150 | $232.11 | $34,816.50 |
DisclosureSEC source: 0001478242-24-000010 · wk-form5_1707430384.xml · derivative · entry 1 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,794 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| February 11, 2023 Filed Feb 13, 2023 22:03 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 54 | $222.84 | $12,033.36 |
DisclosureSEC source: 0001478242-23-000027 · wf-form4_167632579570743.xml · nonDerivative · entry 3 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 899 Read SEC document |
| February 11, 2023 Filed Feb 13, 2023 17:06 UTC |
Panagos ConstantinosSee Remarks
|
Tax withholdingCommon Stock | 1,382 | $222.84 | $307,964.88 |
DisclosureSEC source: 0001478242-23-000030 · wf-form4_167632597146194.xml · nonDerivative · entry 3 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,148 Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 22:03 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 15 | $222.84 | $3,342.60 |
DisclosureSEC source: 0001478242-23-000027 · wf-form4_167632579570743.xml · nonDerivative · entry 2 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 953 Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 17:06 UTC |
Panagos ConstantinosSee Remarks
|
Tax withholdingCommon Stock | 289 | $222.84 | $64,400.76 |
DisclosureSEC source: 0001478242-23-000030 · wf-form4_167632597146194.xml · nonDerivative · entry 2 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,530 Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 22:07 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 303 | $222.84 | $67,520.52 |
DisclosureSEC source: 0001478242-23-000031 · wf-form4_167632601350712.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,419 Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 22:05 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 326 | $222.84 | $72,645.84 |
DisclosureSEC source: 0001478242-23-000029 · wf-form4_167632590634307.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,053 Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 22:04 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 614 | $222.84 | $136,823.76 |
DisclosureSEC source: 0001478242-23-000028 · wf-form4_167632584887189.xml · nonDerivative · entry 2 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,292 Read SEC document |
| February 10, 2023 Filed Feb 13, 2023 22:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 3,496 | $222.84 | $779,048.64 |
DisclosureSEC source: 0001478242-23-000026 · wf-form4_167632574037616.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 749,592 Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:03 UTC |
Cherofsky KeriannSee Remarks
|
Tax withholdingCommon Stock | 60 | $230.31 | $13,818.60 |
DisclosureSEC source: 0001478242-23-000027 · wf-form4_167632579570743.xml · nonDerivative · entry 1 Cherofsky Keriann · CIK 0001940591 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 968 Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 17:06 UTC |
Panagos ConstantinosSee Remarks
|
Tax withholdingCommon Stock | 2,612 | $230.31 | $601,569.72 |
DisclosureSEC source: 0001478242-23-000030 · wf-form4_167632597146194.xml · nonDerivative · entry 1 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,819 Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:07 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 311 | $230.31 | $71,626.41 |
DisclosureSEC source: 0001478242-23-000031 · wf-form4_167632601350712.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,722 Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:05 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 317 | $230.31 | $73,008.27 |
DisclosureSEC source: 0001478242-23-000029 · wf-form4_167632590634307.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,379 Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:04 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 717 | $230.31 | $165,132.27 |
DisclosureSEC source: 0001478242-23-000028 · wf-form4_167632584887189.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,906 Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 22:02 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 4,097 | $230.31 | $943,580.07 |
DisclosureSEC source: 0001478242-23-000026 · wf-form4_167632574037616.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 753,088 Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 17:23 UTC |
Panagos ConstantinosSee Remarks
|
Tax withholdingCommon Stock | 1,341 | $235.84 | $316,261.44 |
DisclosureSEC source: 0001478242-23-000013 · wf-form4_167598137014409.xml · nonDerivative · entry 2 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,431 Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 17:23 UTC |
Panagos ConstantinosSee Remarks
|
GrantCommon Stock | 4,371 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000013 · wf-form4_167598137014409.xml · nonDerivative · entry 1 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,772 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 11, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 7, 2023. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:25 UTC |
Sherbet EricSee Remarks
|
Tax withholdingCommon Stock | 3,267 | $235.84 | $770,489.28 |
DisclosureSEC source: 0001478242-23-000015 · wf-form4_167598149206274.xml · nonDerivative · entry 2 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,696 Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:25 UTC |
Sherbet EricSee Remarks
|
GrantCommon Stock | 8,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000015 · wf-form4_167598149206274.xml · nonDerivative · entry 1 Sherbet Eric · CIK 0001679512 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,963 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 11, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 7, 2023. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:22 UTC |
BOUSBIB ARIDirector · See Remarks
|
Tax withholdingCommon Stock | 44,014 | $235.84 | $10,380,261.76 |
DisclosureSEC source: 0001478242-23-000012 · wf-form4_167598131561083.xml · nonDerivative · entry 2 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 757,185 Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:22 UTC |
BOUSBIB ARIDirector · See Remarks
|
GrantCommon Stock | 87,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000012 · wf-form4_167598131561083.xml · nonDerivative · entry 1 BOUSBIB ARI · CIK 0001184180 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 801,199 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 11, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 7, 2023. Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:24 UTC |
Knightly Kevin CSee Remarks
|
Tax withholdingCommon Stock | 2,090 | $235.84 | $492,905.60 |
DisclosureSEC source: 0001478242-23-000014 · wf-form4_167598143817683.xml · nonDerivative · entry 2 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,033 Read SEC document |
| February 07, 2023 Filed Feb 9, 2023 22:24 UTC |
Knightly Kevin CSee Remarks
|
GrantCommon Stock | 5,829 | $0.00 | $0.00 |
DisclosureSEC source: 0001478242-23-000014 · wf-form4_167598143817683.xml · nonDerivative · entry 1 Knightly Kevin C · CIK 0001350000 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,123 F1 · shares: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted on February 11, 2020. The performance conditions applicable to the award were determined to have been satisfied by the Company's Leadership Development and Compensation Committee on February 7, 2023. Read SEC document |
| November 10, 2022 Filed Feb 9, 2023 22:18 UTC |
DANHAKL JOHN GDirector
|
GrantDeferred Shares · Derivative | 135 | $222.58 | $30,048.30 |
DisclosureSEC source: 0001478242-23-000009 · wf-form5_167598111984084.xml · derivative · entry 4 DANHAKL JOHN G · CIK 0001162644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005 Underlying: Common Stock · 135 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 10, 2022 Filed Feb 9, 2023 22:20 UTC |
GOGGINS COLLEEN ADirector
|
GrantDeferred Shares · Derivative | 150 | $222.58 | $33,387.00 |
DisclosureSEC source: 0001478242-23-000010 · wf-form5_167598117545426.xml · derivative · entry 4 GOGGINS COLLEEN A · CIK 0001189008 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,644 Underlying: Common Stock · 150 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 10, 2022 Filed Feb 9, 2023 22:21 UTC |
Wims Morris LeslieDirector
|
GrantDeferred Shares · Derivative | 124 | $222.58 | $27,599.92 |
DisclosureSEC source: 0001478242-23-000011 · wf-form5_167598126676260.xml · derivative · entry 4 Wims Morris Leslie · CIK 0001908079 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475 Underlying: Common Stock · 124 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.exercise_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. F1 · derivative.expiration_date: Each deferred share is convertible into one share of common stock of IQVIA Holdings Inc. (the "Issuer") upon settlement. The deferred shares become settleable, in accordance with the Issuer's Non-Employee Director Deferral Plan, when the reporting person ceases to be a director, upon a change in control of the Company, or upon death of the reporting person. There is no expiry date. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 17:00 UTC |
Panagos ConstantinosSee Remarks
|
Tax withholdingCommon Stock | 1,818 | $209.39 | $380,671.02 |
DisclosureSEC source: 0001478242-22-000103 · wf-form4_166750923389873.xml · nonDerivative · entry 1 Panagos Constantinos · CIK 0001917705 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,401 Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:16 UTC |
Bruehlman Ronald ESee Remarks
|
Tax withholdingCommon Stock | 2,588 | $233.21 | $603,547.48 |
DisclosureSEC source: 0001478242-22-000090 · wf-form4_165973415234229.xml · nonDerivative · entry 1 Bruehlman Ronald E · CIK 0001604076 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,623 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.